GMDA News and Press, Gamida Cell Ltd. From 11/14/23

Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...

Gamida Cell Ltd. (GMDA) is expected to report $-0.15 for Q3 2023

2023-11-13 13:14:35 ET More on Gamida Cell Gamida Cell rises after Phase 1 data for NK cell therapy Seeking Alpha’s Quant Rating on Gamida Cell Historical earnings data for Gamida Cell Financial information for Gamida Cell For further details s...

BOSTON, Nov. 04, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd . (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today shared new data on the impact of the company’s proprietary nicotinamide (NAM) technology on its allogeneic stem cell therapy omidub...

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its financial results for the third quarter ended September 30, 2023 and provide an updat...

2023-10-17 07:30:08 ET More on Gamida Cell Gamida Cell: The Treacherous Path To Profitability Gamida Cell Ltd. (GMDA) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Gamida Cell Historical earnings data for Gamida Cell Financia...

Data show promising early evidence of anti-tumor activity in patients with relapsed/refractory B cell non-Hodgkin lymphoma Full data readout of Phase 1 study expected in Q1 2024 Gamida Cell Ltd . (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful ther...

Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today issued an update on its operations in Israel. “We remain profoundly saddened by the attacks in Israel this weekend and express our deepest condolences to the people of Isra...

2023-10-09 13:00:03 ET More on InMode, Nano-X, etc. Full Of Potential Red Flags: Breaking Down Nano-X Imaging Nano-X Imaging: Cash Burn Makes It A Hold InMode: Bullish Support Failed To Materialize War between Israel and Hamas pushes U.S.-traded Israeli stock...

2023-10-09 08:23:30 ET More on InMode, Mirati Therapeutics, etc. InMode: Bullish Support Failed To Materialize InMode: Strong Net Cash Position Sets The Stage For Opportunistic Buybacks InMode: Be Greedy When Others Are Fearful Bristol-Myers Squibb to acquire...